Primary Record
Echinocandin B
- In stock
- 6,402 g
- Purity
- 98.3 %
- CAS
- 54651-05-7
Compound Identifiers & Properties
- CAS
- 54651-05-7
- PubChem CID
- 9898144
- SMILES
- CCCCC/C=C\C/C=C\CCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H]([C@H](CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](C)O)C)O)O)O
- Canonical SMILES
- CCCCC/C=C\C/C=C\CCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O
Names & Synonyms
- Echinocandin B
- Antibiotic A 30912A
- CNW0ZW8ZTQ
- 54651-05-7
- UNII-CNW0ZW8ZTQ
- Antibiotic SL 7810F
- echinocandin B nucleus
- Antibiotic A 22082
- RefChem:136218
- ANTIBIOTIC SL-7810
- ANTIBIOTIC A-22082
- A-30912 FACTOR A
- ANTIBIOTIC SL-7810F
- CHEBI:315018
- DTXSID301027535
- orb1986938
- NSC 287461
- SCHEMBL17951640
- C52H81N7O16
- FAUOJMHVEYMQQG-HVYQDZECSA-N
- DTXCID201513127
- ANTIBIOTIC A-30912 FACTOR A
- N1-t-Butyl-N2-phenylpropenamidine
- NSC-287461
- EX-A7012
- BBF-01778
- MFCD01939342
- A 30912A
- AKOS040748303
- ACN-036881
- C52-H81-N7-O16
- CID9898144
- FE29488
- DA-52798
- HY-125723
- J363.403E
- A-22082
- CS-0093422
- A854556
- (9Z,12Z)-N-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,12,15-tetrahydroxy-6,20-bis((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)octadeca-9,12-dienamide
- (9Z,12Z)-N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]octadeca-9,12-dienamide
- 79411-15-7
- (9Z,12Z)-N-{(2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6,20-bis[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}octadeca-9,12-dienamide
- 5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N(2)-[(9Z,12Z)-octadeca-9,12-dienoyl]-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline}
- (1(Z,Z),6(2.ALPHA.,3.BETA.,4.BETA.))-(4R,5R)-4,5-DIHYDROXY-N2-(1-OXO-9,12-OCTADECADIENYL)-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(4-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE
- (9Z,12Z)-N-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,12,15-tetrahydroxy-6,20-bis((1R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacyclohenicosin-9-yl)octadeca-9,12-dienamide;5.1:6-anhydro((4R,5R)-4,5-dihydroxy-N(2)-((9Z,12Z)-octadeca-9,12-dienoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline)
- (9Z,12Z)-N-((3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-11,20,21,25-tetrahydroxy-3,15-bis((1R)-1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo(22.3.0.09,13)heptacosan-18-yl)octadeca-9,12-dienamide
- (9Z,12Z)-N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]octadeca-9,12-dienamide
- Cyclo[L-Thr-[(3S,4S)-3-hydroxy-4-methyl-L-Pro-]-[(4R,5R)-4,5-dihydroxy-N2-[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]-L-Orn*-]-L-Thr-L-t4Hyp-[(3S,4S)-3,4-dihydroxy-4-(4-hydroxyphenyl)-L-Abu-]]